Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon

NCT05935527 is registered in ClinicalTrials.gov with Peregrine Ophthalmic as lead sponsor.

NCT NCT05935527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05935527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon
Lead sponsor
Peregrine Ophthalmic
Phase
Phase 1
Overall status
Completed
Start date
April 28, 2023
Completion date
November 18, 2024
Enrollment
50 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lower eyelid steatoblepharon